English papers

Weak evidence on nalmefene creates dilemmas for clinicians and poses questions for regulators and researchers

Post Views: 1 536 Niamh Fitzgerald, Kathryn Angus, Andrew Elders, Marisa de Andrade, Duncan Raistrick, Nick Heather and Jim McCambridge Version of Record online: 5 JUN 2016 – DOI: 10.1111/add.13438 Abstract Background and aims Nalmefene has been approved in Europe for the…
Savoir plus

R(+)-Baclofen, but Not S(−)-Baclofen, Alters Alcohol Self-Administration in Alcohol-Preferring Rats

Post Views: 2 055 Front. Psychiatry, 18 April 2016 | http://dx.doi.org/10.3389/fpsyt.2016.00068 Irene Lorrai , Paola Maccioni , Gian Luigi Gessa and Giancarlo Colombo Neuroscience Institute, National Research Council of Italy – Cagliari Section, Monserrato, Italy Racemic baclofen [(±)-baclofen] has repeatedly been…
Savoir plus

Risks and Benefits of Nalmefene in the Treatment of Adult Alcohol Dependence: A Systematic Literature Review and Meta- Analysis of Published and Unpublished Double-Blind Randomized Controlled Trials

Post Views: 1 352 Clément Palpacuer 1, Bruno Laviolle 1,2, Rémy Boussageon 3, Jean Michel Reymann 1,2, Eric Bellissant 1,2, Florian Naudet 1,2* 1 INSERM Centre d’Investigation Clinique 1414, Centre Hospitalier Universitaire de Rennes, Rennes, France, 2 Laboratoire de Pharmacologie Expérimentale…
Savoir plus